Johnson & Johnson Faces $800M Levaquin Lawsuit

Raritan, NJ: Johnson & Johnson (J&J) reportedly faces an $800 million Levaquin lawsuit, alleging the company hid vital information about side effects linked to the drug. Plaintiffs in the Levaquin antibiotic lawsuit allege Johnson & Johnson, and its subsidiary Janssen Pharmaceuticals, deliberately mislabeled Levaquin. In addition to J&J being named in the lawsuit, former FDA commissioner Margaret Hamberg is also listed and faces allegations of violations of the Racketeer Influenced and Corrupt Organizations (RICO) Act


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s